How cannabinoids affect memory and reward-seeking behavior

Endocannabinoid Control of Cholinergic Transmission and the Pursuit of Reward

NIH-funded research University of Maryland Baltimore · NIH-11102975

This study is looking at how a brain chemical called acetylcholine works with another type of receptor related to cannabis to affect memory and motivation, which could help us find new ways to treat Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11102975 on NIH RePORTER

What this research studies

This research investigates the role of acetylcholine in cognition and how it interacts with cannabinoid receptors in the brain, particularly in the hippocampus, which is crucial for memory. By studying both animal models and human subjects, the research aims to understand how these interactions influence working memory and the motivation to seek rewards. The approach includes examining the effects of cannabinoid type 1 receptors on cholinergic signaling and their implications for memory processes and behavior. This could lead to new insights into treating conditions like Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing cognitive decline or have been diagnosed with Alzheimer's disease.

Not a fit: Patients who are under 21 years old or do not have cognitive impairments related to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for enhancing memory and motivation in patients with Alzheimer's disease.

How similar studies have performed: Previous studies have shown promising results in understanding the role of acetylcholine and cannabinoids in cognition, suggesting that this research builds on established findings.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.